Neuraxis (NRXS) Interest & Investment Income (2023)
Neuraxis' (NRXS) quarterly Interest & Investment Income came in at $2103.0 in Q3 2023.
Powered by 
Analysis
Neuraxis (NRXS) Interest & Investment Income (2023) Analysis & Trends
Neuraxis has disclosed Interest & Investment Income across 1 years of filings, most recently posting $2103.0 for Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | - |
| 10 | Neuraxis | 69.33 Mn | 61.00 Mn | - | - |